Showing results (281-290 of 754) with videos related to
Sort By:
Pageof 76
Biorxiv : the Preprint Server for Biology|February 27, 2024
A whole-genome CRISPR screen identifies the spindle accessory checkpoint as a locus of nab-paclitaxel resistance in pancreatic cancer cellsPriya Mondal, George Alyateem, Allison V Mitchell, et al.Journal of Cellular Physiology|March 4, 2000
Decreased accumulation of [14C]carboplatin in human cisplatin-resistant cells results from reduced energy-dependent uptakeD W Shen, S Goldenberg, I Pastan, et al.Trends in Molecular Medicine|February 5, 2014
Simplifying the complexity of resistance heterogeneity in metastasisOrit Lavi, James M Greene, Doron Levy, et al.Biotechniques|February 1, 1991
Pseudomonas exotoxin fusion proteins are potent immunogens for raising antibodies against P-glycoproteinE P Bruggemann, V Chaudhary, M M Gottesman, et al.Cancer Research|October 29, 2013
The role of cell density and intratumoral heterogeneity in multidrug resistanceOrit Lavi, James M Greene, Doron Levy, et al.Molecular Pharmacology|April 1, 1994
Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substratesW D Stein, C Cardarelli, I Pastan, et al.Journal of Cellular Physiology|April 1, 1982
Rous sarcoma virus transformed cells are resistant to cyclic AMPC W Roth, T Singh, I Pastan, et al.Cell|April 1, 1981
Protein degradation in E. coli: the lon mutation and bacteriophage lambda N and cII protein stabilityS Gottesman, M Gottesman, J E Shaw, et al.The Journal of Cell Biology|June 1, 1988
An acid protease secreted by transformed cells interferes with antigen processingK McCoy, S Gal, R H Schwartz, et al.Science (New York, N.Y.)|January 24, 1992
Modulation of activity of the promoter of the human MDR1 gene by Ras and p53K V Chin, K Ueda, I Pastan, et al.Pageof 76